Detalles de la búsqueda
1.
Burden of disease among patients with prevalent Crohn's disease: results from a large German sickness fund.
Int J Colorectal Dis
; 38(1): 74, 2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36939923
2.
Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis.
Acta Derm Venereol
; 102: adv00631, 2022 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904684
3.
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE).
Scand J Gastroenterol
; 54(6): 718-725, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31184512
4.
Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.
Am J Gastroenterol
; 113(11): 1678-1688, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30022113
5.
Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn's Disease patients: A retrospective analysis using German claims data.
Therap Adv Gastroenterol
; 15: 17562848221130554, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36353736
6.
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.
Eur J Gastroenterol Hepatol
; 32(12): 1507-1513, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868649
7.
CCR3, CCR5, interleukin 4, and interferon-gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis.
J Rheumatol
; 30(9): 1928-34, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12966592
Resultados
1 -
7
de 7
1
Próxima >
>>